MIMEDX GROUP, INC.
For the period ended Dec 31, 2025. Filed Feb 25, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 25, 2026
MDXG$3.37+1.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations – For the years ended
(in thousands, except share and per share data)
| Year Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Net sales | $418,630 | $348,879 | $321,477 |
| Cost of sales | 73,013 | 60,073 | 54,634 |
| Gross profit | 345,617 | 288,806 | 266,843 |
| Operating expenses: | |||
| Selling, general and administrative | 266,194 | 225,087 | 211,124 |
| Research and development | 15,097 | 12,341 | 12,665 |
| Investigation, restatement and related | — | (8,698) | 5,176 |
| Amortization of intangible assets | 439 | 765 | 762 |
| Impairment of intangible assets | — | 446 | — |
| Operating income | 63,887 | 58,865 | 37,116 |
| Other income (expense), net | |||
| Interest income (expense), net | 2,933 | (1,006) | (6,457) |
| Other expense, net | (558) | (565) | (26) |
| Income from continuing operations before income tax | 66,262 | 57,294 | 30,633 |
| Income tax provision (expense) benefit from continuing operations | (17,684) | (15,296) | 36,806 |
| Net income from continuing operations | 48,578 | 41,998 | 67,439 |
| Income (loss) from discontinued operations, net of tax | — | 421 | (9,211) |
| Net income | $48,578 | $42,419 | $58,228 |
| Net income available to common stockholders from continuing operations | $48,578 | $41,998 | $55,796 |
| Basic net income (loss) per common share: | |||
| Continuing operations | $0.33 | $0.29 | $0.48 |
| Discontinued operations | — | — | (0.08) |
| Basic net income per common share: | $0.33 | $0.29 | $0.40 |
| Diluted net income (loss) per common share: | |||
| Continuing operations | $0.32 | $0.28 | $0.43 |
| Discontinued operations | — | — | (0.06) |
| Diluted net income (loss) per common share: | $0.32 | $0.28 | $0.37 |
| Weighted average common shares outstanding - basic | 147,793,069 | 146,979,354 | 116,495,810 |
| Weighted average common shares outstanding - diluted | 149,724,507 | 149,049,197 | 145,962,462 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.